Display options
Share it on

Clin Mol Pathol. 1995 Jun;48(3):M153-7. doi: 10.1136/mp.48.3.m153.

Insulin-like growth factor II prevents apoptosis in a human teratoma derived cell line.

Clinical molecular pathology

M Granerus, P Bierke, W Zumkeller, J Smith, W Engström, P N Schofield

Affiliations

  1. Department of Pathology, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, PO Box 7028, S-75007 Uppsala, Sweden.

PMID: 16695997 PMCID: PMC407949 DOI: 10.1136/mp.48.3.m153

Abstract

Aim-To study how insulin-like growth factor II (IGF-II) affects the behaviour of human teratoma cells.Methods-The human pluripotential teratoma cell line Tera 2 was cultured under serum-free conditions in the presence or absence of IGF-II. Effects on cell proliferation and apoptosis as well as on the expression of the proto-oncogene c-myc were studied.Results-In this study we show that Tera 2 cells deprived of serum undergo programmed cell death (apoptosis). The onset of nuclear fragmentation was observed 12 hours after serum withdrawal. The morphological changes of the Tera 2 cell nuclei were confirmed by the occurrence of a nucleosome ladder. However, the constitutive expression of the proto-oncogene c-myc was not decreased in parallel with initiation of apoptosis. The apoptotic response to serum withdrawal could be counteracted by simultaneous addition of IGF-II. In addition it was found that human testicular tumours (seminoma and embryonal carcinoma) contain raised levels of insulin-like growth factors.Conclusions-The precise roles of IGF-I and IGF-II have been unclear, and there is overwhelming evidence against these factors as primarily transforming agents. The finding that IGF-II apparently counteracts apoptosis in vitro may well explain its effects on tumours in vivo.

References

  1. EMBO J. 1994 Jul 15;13(14):3286-95 - PubMed
  2. J Urol. 1993 Aug;150(2 Pt 2):613-6 - PubMed
  3. J Cell Sci. 1987 Aug;88 ( Pt 1):57-64 - PubMed
  4. J Reprod Fertil. 1990 Mar;88(2):481-90 - PubMed
  5. Cancer Cells. 1990 Aug-Sep;2(8-9):275-80 - PubMed
  6. Biochem Soc Trans. 1990 Apr;18(2):343-5 - PubMed
  7. Anticancer Res. 1994 Mar-Apr;14(2A):533-8 - PubMed
  8. Int J Androl. 1987 Feb;10(1):79-84 - PubMed
  9. Development. 1990 Jul;109(3):605-11 - PubMed
  10. J Cell Sci. 1988 Jul;90 ( Pt 3):475-84 - PubMed
  11. Anal Biochem. 1983 Jul 1;132(1):6-13 - PubMed
  12. Br J Cancer. 1993 Feb;67(2):205-8 - PubMed
  13. Nature. 1992 Apr 2;356(6368):397-400 - PubMed
  14. Zoolog Sci. 1994 Apr;11(2):167-74 - PubMed
  15. Genes Dev. 1993 Apr;7(4):529-34 - PubMed
  16. Nutrition. 1993 May-Jun;9(3):271-3 - PubMed
  17. Cell. 1992 Apr 3;69(1):119-28 - PubMed
  18. Development. 1993 Aug;118(4):1089-94 - PubMed

Publication Types